RNAZ
Transcode Therapeutics Inc
$1.63
0.08 (4.68%) Today
— up— down
Market Cap
$28M-84.7%
Revenue (TTM)
$0
$0Net Income (TTM)
$-49,815,124
$-49,815,124EPS (TTM)
-47.00
-47.00Shares Out
1.06M
1.06MOpen
$1.63
$1.63Previous Close
$1.71
$1.71Day Range
$1.60 – $1.81
$1.60 – $1.8152-Week Range
$1.58 – $20.99
$1.58 – $20.99Beta
1.27
1.27Volume
10.94K
10.94KAvg Volume
71.28K
71.28KAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout RNAZ
Related
News
N/AN/A
TransCode Reports Continued Disease Stabilization and Extended Treatment Duration with TTX-MC138 in Ongoing Phase 1a Clinical Trial Follow-Up
Yahoo · 1d ago
TransCode Therapeutics Announces Updated Clinical Data From Phase 1a Clinical Trial Of TTX-MC138, Reinforcing Evidence Of Antitumor Activity In Heavily Pretreated Patients With Advanced Solid Tumors
Benzinga · 1d ago